ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · XNASCIK 2023311fmd_1YA04FKSB494N780MWZ9NGH20HManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Dec 31, 2025, 4 periods
| Line item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Total revenues | 210 | 222 | 981 |
| Cost of revenue | 22 | 31 | 29 |
| Gross profit | 188 | 191 | 952 |
| Research and development | 743 | 707 | 947 |
| Interest expense | 53 | 96 | 64 |
| Income before taxes | (887) | (933) | (395) |
| Income tax expense | (4) | (7) | 10 |
| Net income from continuing operations | (883) | (926) | (406) |
| Net income | (883) | (926) | (405) |